True North has acquired significant minority stake in Embio Limited (“Embio”), a leading regulated markets-focused manufacturer of complex API and advanced intermediates, and a key player in controlled substances sector.
The transaction team was led by Aditi Manchanda, and Abhishek Kalra, Partners; with support from Naimi Kamdar and Chandni Ochani, Principal Associates; and Rajat Pareek, Associate.
The due diligence team was led by Aditi Manchanda, and Abhishek Kalra Partners; with support from Chandni Ochani, Principal Associate; Kaushik Raichura, Senior Associate; and Rajat Pareek, Associate.
Biplab Lenin, Partner; with support from Anam Chowdhary, Associate; assisted on pharma and healthcare due diligence and related aspects for the transaction.
Arya Tripathy, Partner; with support from Milind Yadav, Associate, assisted on intellectual property, information technology and data privacy due diligence and related aspects for the transaction.
Sowmya Kumar, Partner; with support from Luv Saggi, Director — Employment; and Tara Thakur, Associate, assisted on employment due diligence and related aspects for the transaction.
Dhruv Rajain, Partner; with support from Ridhima Sethi, Associate, assisted on CCI analysis.
Siddharth Singh, Partner; with support from Rushi Panchal, Associate, assisted on real estate related aspects for the transaction.
